The Technology Development Fund (TDF) is an internal funding program that provides pre-commercial development support to advance intellectual property along the commercialization pathway. By funding and fast-tracking pivotal proof of concept/validation work, prototype development, and pre-clinical and clinical development, the TDF helps answer questions about whether technologies work, making them both more attractive and less risky to potential licensing and/or business partners. There are two award cycles per year, with applications due in April and September. Applications are reviewed by the TDF Committee, a group of industry experts in the commercialization field with business, scientific and technical backgrounds. During each award cycle, up to $50,000 in TDF funding is awarded to one or multiple awardees. Funds may be distributed in their entirety or on a milestone basis as determined by the TDF Committee. Awardees are expected to work actively with the Office of Technology Commercialization (OTC) to transfer their inventions to the private sector for commercialization. The OTC manages the fund and its application process. Once the TDF Committee has selected the cycle’s awardees, the OTC notifies applicants of their award status and distributes awarded funds. Applicants who do not receive awards may reapply to be reconsidered during the next funding cycle. Employees are invited to learn more and apply to the current award cycle on the OTC’s ANCHOR site.
The Technology Development Fund (TDF) is an internal funding program that provides pre-commercial development support to advance intellectual property along the commercialization pathway. By funding and fast-tracking pivotal proof of concept/validation work, prototype development, and pre-clinical and clinical development, the TDF helps answer questions about whether technologies work, making them both more attractive and less risky to potential licensing and/or business partners.
There are two award cycles per year, with applications due in April and September. Applications are reviewed by the TDF Committee, a group of industry experts in the commercialization field with business, scientific and technical backgrounds. During each award cycle, up to $50,000 in TDF funding is awarded to one or multiple awardees. Funds may be distributed in their entirety or on a milestone basis as determined by the TDF Committee. Awardees are expected to work actively with the Office of Technology Commercialization (OTC) to transfer their inventions to the private sector for commercialization.
The OTC manages the fund and its application process. Once the TDF Committee has selected the cycle’s awardees, the OTC notifies applicants of their award status and distributes awarded funds. Applicants who do not receive awards may reapply to be reconsidered during the next funding cycle.
Employees are invited to learn more and apply to the current award cycle on the OTC’s ANCHOR site.
